… tissues/cells is critical to some newly discovered therapies, such as specialized pro-resolving
mediators that have been found highly effective in the treatment of inflammatory disorders, …

… Another strategy to improve the pharmacokinetic profile of the drug delivery to the inflammatory
disorders and cancer is the third level targeting, ie intracellular organelle targeting by NPs…

… monocytes, leading to monocyte apoptosis, thereby markedly improving disease symptoms
in multiple inflammatory disorders in animal models, including DSS-induced colitis [144]. …

… This review showcases local drug delivery systems in different inflammatory … drug delivery
systems in different inflammatory diseases, including the targets well-known to drug delivery …

… offers selective drug targeting to the inflamed tissue. Here we focus on nanocarrier-based
drug delivery strategies for the treatment of common inflammatory disorders like rheumatoid …

… rational design of inflammation-specific drug delivery systems (… stimuli for triggered delivery
of anti-inflammatory agents in a … may lead to autoimmune or autoinflammatory disorders, …

… -based drug delivery systems with anti-inflammatory effects. Inflammation: Current Status …
NSAIDs are anti-inflammatory molecules used to treat inflammatory disorders. Kalangi et al. …

… link between these disorders is … drug delivery. Here, we discuss the role of macrophages
in the initiation and progression of various inflammatory diseases, summarize the leading drugs …

… main innovative nanomedicine approaches that have been proposed in the past five years
for the resolution of inflammatory disorders, finally focusing on those currently in clinical trials. …

… Inflammatory bowel disease (IBD) is a chronic illness characterized by relapsing inflammation
of the intestines. The disorder is stratified according to the severity and is marked by its …